A Molybdenum Disulfide Nanozyme with Charge-Enhanced Activity for Ultrasound-Mediated Cascade-Catalytic Tumor Ferroptosis

Angew Chem Int Ed Engl. 2023 Mar 6;62(11):e202217448. doi: 10.1002/anie.202217448. Epub 2023 Feb 1.

Abstract

The deficient catalytic activity of nanozymes and insufficient endogenous H2 O2 in the tumor microenvironment (TME) are major obstacles for nanozyme-mediated catalytic tumor therapy. Since electron transfer is the basic essence of catalysis-mediated redox reactions, we explored the contributing factors of enzymatic activity based on positive and negative charges, which are experimentally and theoretically demonstrated to enhance the peroxidase (POD)-like activity of a MoS2 nanozyme. Hence, an acidic tumor microenvironment-responsive and ultrasound-mediated cascade nanocatalyst (BTO/MoS2 @CA) is presented that is made from few-layer MoS2 nanosheets grown on the surface of piezoelectric tetragonal barium titanate (T-BTO) and modified with pH-responsive cinnamaldehyde (CA). The integration of pH-responsive CA-mediated H2 O2 self-supply, ultrasound-mediated charge-enhanced enzymatic activity, and glutathione (GSH) depletion enables out-of-balance redox homeostasis, leading to effective tumor ferroptosis with minimal side effects.

Keywords: Ferroptosis; Nanozymes; Reactive Oxygen Species; Tumor Therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Catalysis
  • Ferroptosis*
  • Glutathione
  • Humans
  • Hydrogen Peroxide
  • Molybdenum
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / drug therapy
  • Tumor Microenvironment

Substances

  • molybdenum disulfide
  • Molybdenum
  • cinnamaldehyde
  • Glutathione
  • Hydrogen Peroxide